Literature DB >> 32217552

Save the Brain First: CTA and Mechanical Thrombectomy in Patients at Risk for Contrast-Induced Nephropathy.

X Li1, S Partovi1.   

Abstract

Entities:  

Mesh：

Year:  2020        PMID： 32217552      PMCID： PMC7144638          DOI： 10.3174/ajnr.A6515

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN： 0195-6108            Impact factor:   3.825


× No keyword cloud information.
  20 in total

1.  The risk of acute radiocontrast-mediated kidney injury following endovascular therapy for acute ischemic stroke is low.

Authors:  Y Loh; D L McArthur; P Vespa; Z-S Shi; D S Liebeskind; R Jahan; N R Gonzalez; S Starkman; J L Saver; S Tateshima; G R Duckwiler; F Viñuela
Journal:  AJNR Am J Neuroradiol       Date:  2010-06-03       Impact factor: 3.825

2.  Contemporary incidence, predictors, and outcomes of acute kidney injury in patients undergoing percutaneous coronary interventions: insights from the NCDR Cath-PCI registry.

Authors:  Thomas T Tsai; Uptal D Patel; Tara I Chang; Kevin F Kennedy; Frederick A Masoudi; Michael E Matheny; Mikhail Kosiborod; Amit P Amin; John C Messenger; John S Rumsfeld; John A Spertus
Journal:  JACC Cardiovasc Interv       Date:  2014-01       Impact factor: 11.195

3.  Stroke incidence and mortality trends in US communities, 1987 to 2011.

Authors:  Silvia Koton; Andrea L C Schneider; Wayne D Rosamond; Eyal Shahar; Yingying Sang; Rebecca F Gottesman; Josef Coresh
Journal:  JAMA       Date:  2014-07-16       Impact factor: 56.272

Review 4.  Evaluation of Short-Term Changes in Serum Creatinine Level as a Meaningful End Point in Randomized Clinical Trials.

Authors:  Steven G Coca; Azadeh Zabetian; Bart S Ferket; Jing Zhou; Jeffrey M Testani; Amit X Garg; Chirag R Parikh
Journal:  J Am Soc Nephrol       Date:  2015-12-28       Impact factor: 10.121

5.  Time is brain--quantified.

Authors:  Jeffrey L Saver
Journal:  Stroke       Date:  2005-12-08       Impact factor: 7.914

6.  Safety of cerebral angiography and neuroendovascular therapy in patients with chronic kidney disease.

Authors:  Jae Kim; Shailesh Male; Bharathi D Jagadeesan; Christopher Streib; Ramachandra P Tummala
Journal:  Neuroradiology       Date:  2018-03-01       Impact factor: 2.804

7.  Prophylactic hydration to protect renal function from intravascular iodinated contrast material in patients at high risk of contrast-induced nephropathy (AMACING): a prospective, randomised, phase 3, controlled, open-label, non-inferiority trial.

Authors:  Estelle C Nijssen; Roger J Rennenberg; Patty J Nelemans; Brigitte A Essers; Marga M Janssen; Marja A Vermeeren; Vincent van Ommen; Joachim E Wildberger
Journal:  Lancet       Date:  2017-02-21       Impact factor: 79.321

8.  No increased risk for contrast-induced nephropathy after multiple CT perfusion studies of the brain with a nonionic, dimeric, iso-osmolal contrast medium.

Authors:  S Langner; S Stumpe; M Kirsch; M Petrik; N Hosten
Journal:  AJNR Am J Neuroradiol       Date:  2008-06-04       Impact factor: 3.825

9.  Intravenous contrast material-induced nephropathy: causal or coincident phenomenon?

Authors:  Robert J McDonald; Jennifer S McDonald; John P Bida; Rickey E Carter; Chad J Fleming; Sanjay Misra; Eric E Williamson; David F Kallmes
Journal:  Radiology       Date:  2013-01-29       Impact factor: 11.105

10.  Functional contrast-enhanced CT for evaluation of acute ischemic stroke does not increase the risk of contrast-induced nephropathy.

Authors:  F O Lima; M H Lev; R A Levy; G S Silva; M Ebril; E C de Camargo; S Pomerantz; A B Singhal; D M Greer; H Ay; R Gilberto González; W J Koroshetz; W S Smith; K L Furie
Journal:  AJNR Am J Neuroradiol       Date:  2009-12-31       Impact factor: 3.825
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.